Kent Amsberry has extensive experience in pharmaceutical product development and regulatory consulting. Kent has held leadership positions at various companies, leading groups responsible for sterile product formulation, process development, and analytical development for parenteral products. Currently, Kent serves as the Director at Cardinal Health Regulatory Sciences, leading the Advanced Therapy Product Development group. Kent is dedicated to providing pharmaceutical and regulatory consulting to clients at all stages of development in the Advanced Therapy field.
April, 2022 - present
July, 2016